PETRI DISH PERSPECTIVES
PETRI DISH PERSPECTIVES
Manead Khin
Episode 38: Biogen
24 minutes Posted Jan 15, 2026 at 11:00 am.
Founders, Ideology, and the Birth of Biogen (1978–1985)
Interferons, the IPO, and Biogen’s First Proof Point (1985–1997)
Neurology Deepens (1997–2010)
Why Alzheimer’s; The Strategic Pivot (2010–2021)
Leqembi and the Attempt at Redemption (2022–Present)
Alumni and the Biogen Diaspora
Lessons From Biogen
What’s Next for Biogen?
0:00
24:09
Download MP3
Show notes
Send us Fan Mail Biogen is one of the most influential and controversial companies in modern biotechnology. Founded in the late 1970s by Nobel-level scientists who believed recombinant DNA would redefine medicine, Biogen helped turn neurology into a commercial field long before most pharma companies dared to enter it. In this episode, we trace Biogen’s full journey, from its academic origins and the rise of interferon therapies for multiple sclerosis, to blockbuster drugs like Avonex and Tysa...